Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 384,985 | 282,212 | 177,695 | 257,996 | 253,637 |
| Marketable Securities | 571,489 | 569,246 | 641,991 | 589,023 | 508,359 |
| Receivables | 166,330 | 148,384 | 148,231 | 139,438 | 119,686 |
| Inventories | 32,372 | 31,574 | 34,670 | 29,097 | 26,124 |
| TOTAL | $1,224,545 | $1,096,016 | $1,062,113 | $1,076,422 | $960,553 |
| Non-Current Assets | |||||
| PPE Net | 17,107 | 14,652 | 7,511 | 3,708 | 3,547 |
| Intangibles | 103,448 | 106,171 | 108,893 | 111,615 | 114,338 |
| Other Non-Current Assets | 397,800 | 388,391 | 385,678 | 139,026 | 147,117 |
| TOTAL | $518,355 | $509,214 | $502,082 | $254,349 | $265,002 |
| Total Assets | $1,742,900 | $1,605,230 | $1,564,195 | $1,330,771 | $1,225,555 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 44,566 | 12,246 | 10,903 | 21,747 | 20,097 |
| Accrued Expenses | 316,870 | 293,278 | 266,211 | 334,837 | 309,927 |
| TOTAL | $361,436 | $305,524 | $277,114 | $356,584 | $330,024 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 74,855 | 51,640 | 59,691 | 56,915 | 73,149 |
| TOTAL | $74,855 | $51,640 | $59,691 | $56,915 | $73,149 |
| Total Liabilities | $436,291 | $357,164 | $336,805 | $413,499 | $403,173 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 172,306 | 171,236 | 170,495 | 169,182 | 168,712 |
| Common Shares | 16 | 16 | 16 | 16 | 16 |
| Retained earnings | -1,778,249 | -1,809,749 | -1,813,386 | -2,086,954 | -2,158,733 |
| Other shareholders' equity | -958 | -563 | 1,445 | 989 | 406 |
| TOTAL | $1,306,609 | $1,248,066 | $1,227,390 | $917,272 | $822,382 |
| Total Liabilities And Equity | $1,742,900 | $1,605,230 | $1,564,195 | $1,330,771 | $1,225,555 |